DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

Cue Biopharma Q4 EPS $(0.37) Beats $(0.4) Estimate, Sales $1.049M May Not Compare To $2.4M Estimate

Cue Biopharma (NASDAQ:CUE) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(0.4) by 7.5 percent. The company reported quarterly sales of $1.049 million which missed the

Benzinga · 03/17/2020 20:07

Cue Biopharma (NASDAQ:CUE) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(0.4) by 7.5 percent. The company reported quarterly sales of $1.049 million which missed the analyst consensus estimate of $2.4 million by 56.29 percent.